Demand Backed by Rules
Inspection rules for reused batteries are lifting diagnostic demand. Standalone sales in the first quarter of 2026 rose 63.1% from a year earlier. KB Securities sees room to expand into in-use battery diagnostics.
PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close
Mintech's third-quarter 2026 sales fell to KRW 844 million, yet operating losses narrowed in both the second and third quarters, leaving orders and battery inspection rules as the key variables.
Annual sales reached KRW 21 billion in 2025, rising for a second straight year, while the operating loss narrowed to KRW 8.8 billion from KRW 11 billion.
Third-quarter 2026 sales were KRW 844 million, down 91.9% from a year earlier, and have declined for four straight quarters since the fourth quarter of 2025.
The operating loss shrank from KRW 2.68 billion in the first quarter of 2026 to KRW 1.99 billion and then KRW 1.62 billion, and third-quarter owner net income turned to a KRW 33.88 million profit.
A KRW 10.87 billion semiconductor module inspection equipment contract disclosed in May 2026 equals 51.72% of 2025 sales.
Mandatory safety inspections for reused batteries are lifting diagnostic demand, and standalone sales in the first quarter of 2026 rose 63.1% from a year earlier.
Mintech, founded in 2015 and listed on KOSDAQ in May 2024, makes battery inspection and diagnostic equipment. Its core technology is electrochemical impedance spectroscopy (EIS), which KB Securities described as the only commercialized version of the method in Korea.
Main products are battery performance diagnosis solutions, charge-discharge test equipment and reused ESS. KB Securities put the three-year average revenue mix at 56% for diagnosis solutions, 36% for charge-discharge equipment and 10% for reused ESS.
A Jobkorea compilation as of March 2026 showed battery diagnosis systems at 54%, charge-discharge equipment at 26% and other items at 20%, so diagnosis remains the largest category in both compilations.
KB Securities said in a 2025 report that sales had mainly come from used-battery projects tied to public-sector demand, while manufacturing-stage orders were small pilot-line contracts.
A 2024 KB Securities report said the company was widening its customer base to cell makers including LG Energy Solution and Volkswagen PowerCo as battery lines expanded in the United States and Europe.
A semiconductor module inspection equipment contract worth KRW 10.87 billion, disclosed in May 2026, was signed with a counterparty the company did not name at the customer's request.
KB Securities said the company supplied a solid-state battery process inspection tool it developed in-house to a domestic battery maker in October 2025. The same broker cited technology validation across more than 3,000 batteries as the basis for the company's competitive position in orders.
| Quarter | Revenue | Operating profit | Op. margin |
|---|---|---|---|
| 2025Q3 | ₩10.4B | ₩200M | 1.6% |
| 2025Q4 | ₩8.9B | -₩1.3B | −15.0% |
| 2026Q1 | ₩1.6B | -₩2.7B | −165.8% |
| 2026Q2 | ₩1.5B | -₩2B | −129.3% |
| 2026Q3 | ₩800M | -₩1.6B | −192.3% |
| Year | Revenue | Operating profit | Net income (parent) | Op. margin | ROE | Debt-to-equity |
|---|---|---|---|---|---|---|
| 2023 | ₩17.5B | -₩6.6B | -₩8.5B | −37.6% | −56.1% | 173.4% |
| 2024 | ₩20.9B | -₩11B | -₩14.5B | −52.6% | −46.5% | 121.2% |
| 2025 | ₩21B | -₩8.8B | -₩2.5B | −41.9% | −7.4% | 65.2% |
Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-14
Annual sales were KRW 17.5 billion in 2023, KRW 20.9 billion in 2024 (up 18.9% year on year) and KRW 21 billion in 2025 (up 0.8%), rising for two straight years from 2024 through 2025, with 2025 the largest year of the three.
Operating losses were KRW 6.6 billion in 2023, KRW 11 billion in 2024 and KRW 8.8 billion in 2025, a loss in each of the three years; the loss widened in 2024 and narrowed in 2025. KB Securities attributed the 2024 widening to higher R&D and depreciation costs.
The operating margin was -37.6% in 2023, -52.6% in 2024 and -41.9% in 2025. Owner net losses were KRW 8.5 billion, KRW 14.5 billion and KRW 2.51 billion in the same years, and net income including non-controlling interests moved in the same direction.
The debt ratio fell from 173.4% in 2023 to 121.2% in 2024 and 65.2% in 2025, when total equity was KRW 33.8 billion and total liabilities were KRW 22 billion. Operating cash flow was -KRW 3.4 billion in 2023, -KRW 9.76 billion in 2024 and -KRW 4.71 billion in 2025, an outflow in all three years.
In the third quarter of 2025, sales were KRW 10.4 billion, operating profit KRW 161 million and owner net income KRW 4.26 billion; KB Securities read this as sales concentrating in that quarter.
Fourth-quarter 2025 sales were KRW 8.87 billion, down 14.4% from the prior quarter, and the company swung to an operating loss of KRW 1.33 billion. First-quarter 2026 sales were KRW 1.61 billion (down 81.8% quarter on quarter), with an operating loss of KRW 2.68 billion and an owner net loss of KRW 2.91 billion.
Second-quarter 2026 sales were KRW 1.54 billion, with an operating loss of KRW 1.99 billion and an owner net loss of KRW 2.19 billion.
Third-quarter 2026 sales were KRW 844 million, down 91.9% from a year earlier; the operating loss of KRW 1.62 billion was a swing from a year-earlier profit, and owner net income was KRW 33.88 million. Owner net losses over the latest four quarters totaled KRW 6.88 billion.
Demand for battery diagnostics first arose in the reuse stage of used batteries, and since 2024 battery safety has become a central issue, strengthening diagnostic rules.
The introduction of inspection rules for reused batteries has raised demand for performance and safety assessment, a point that recurs in the company's first-quarter 2026 results.
Industry commentary expects the diagnostics market to grow as electric vehicle sales rise and safety inspections for reused batteries take effect. KB Securities sees expansion into in-use battery diagnostics as an opportunity, but the pace at which the rules are implemented will determine how fast that happens.
KB Securities said diagnostic demand in cell manufacturing arises from battery lines expanding in the United States and Europe.
Few Korean companies have commercialized EIS-based diagnostics, and KB Securities said the method is more time- and cost-efficient than conventional charge-discharge testing, with a high technical barrier.
Mintech is extending equipment demand beyond batteries, as the semiconductor module contract shows, but its dependence on battery customers remains high.
Unlike large-cap electrical equipment peers such as LS ELECTRIC and HD Hyundai Electric, Mintech is concentrated in battery test equipment, so sector averages are not a direct benchmark.
Before its 2024 listing, the company set a 2026 sales target of KRW 1.055 billion, according to an Electronic Times report. Sales were KRW 21 billion in 2025, and quarterly sales in the first three quarters of 2026 were KRW 1.61 billion, KRW 1.54 billion and KRW 844 million, a wide gap from that target.
A 2024 report quoted the company as planning to spend KRW 11.4 billion on battery inspection and diagnostic facilities in 2026. The main contract for the semiconductor module inspection equipment disclosed in May 2026 was reported to run for about 2.5 years on an in-house production basis.
When that contract starts to show up in reported sales is a checkpoint for results after 2027. KB Securities cited in-use battery diagnostics as an opportunity in its 2024 report, and whether that expansion turns into orders is the next test.
Cell makers' capacity schedules and the timing of government inspection rules will shape order volume. Whether operating losses keep narrowing and whether sales stop declining will be the next points to confirm in reported results.
The price-to-earnings ratio cannot be calculated because the company has posted owner net losses over the latest four quarters. The price-to-book ratio sits near net asset value, so the premium over book equity is not large.
Compared with the past PER band, the current figure falls in a loss-making range where earnings-based bands cannot be applied directly. The dividend yield is below the sector average.
Owner net income turned to a profit in the third quarter of 2026, but the four-quarter cumulative result is still a net loss, which limits earnings-based comparison. In April 2026 Kim Ho-gi, an executive director, reported that his holdings rose after exercising appraisal rights. The key to valuation is how quickly the KRW 33.8 billion in total equity converts into earnings.
PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-14
Inspection rules for reused batteries are lifting diagnostic demand. Standalone sales in the first quarter of 2026 rose 63.1% from a year earlier. KB Securities sees room to expand into in-use battery diagnostics.
A KRW 10.87 billion semiconductor module inspection contract disclosed in May 2026 equals 51.72% of 2025 sales. Its roughly two-and-a-half-year term adds revenue visibility. It is an example of extending demand beyond batteries into semiconductor inspection equipment.
The operating loss narrowed from KRW 2.68 billion in the first quarter of 2026 to KRW 1.99 billion and then KRW 1.62 billion. Third-quarter owner net income turned to a KRW 33.88 million profit. The 2025 annual operating loss also narrowed from the prior year.
Third-quarter 2026 sales were KRW 844 million, down 91.9% from a year earlier. Sales have fallen for four straight quarters since the fourth quarter of 2025, weakening the revenue base. The gap from the 2026 sales target of KRW 1.055 billion set before the listing is wide.
Operating losses ran for three straight years from 2023 through 2025, and owner net losses over the latest four quarters totaled KRW 6.88 billion. In 2024 higher R&D and depreciation pushed the operating loss to KRW 11 billion. If the planned KRW 11.4 billion of 2026 facility spending continues, fixed-cost pressure remains.
KB Securities cited dependence on downstream battery demand and on policy as a risk. It said results will become visible only once rules are established and downstream demand recovers. Some orders have undisclosed counterparties, which makes customer concentration hard to assess from outside.
Demand for battery inspection and diagnostics depends heavily on when government rules take effect. If implementation slips, the timing of demand growth could slip with it. The pace of rule adoption is an external variable the company cannot control.
Quarterly sales fell to KRW 1.61 billion, KRW 1.54 billion and KRW 844 million across the first three quarters of 2026, so gaps in orders showed up in results immediately. A single large contract is comparable in size to annual sales, which makes reported results volatile.
The KRW 10.4 billion of sales in the third quarter of 2025 is another example of revenue concentrated in one quarter.
Total liabilities were KRW 22 billion and total equity KRW 33.8 billion at the end of 2025. Operating cash flow was negative in each of the three years from 2023 through 2025. If the planned KRW 11.4 billion of 2026 facility spending is executed, cash needs will rise.
Whether fourth-quarter sales stay near the KRW 844 million of the third quarter, and whether revenue recognition on the semiconductor module contract begins, are the points to watch.
Full-year 2026 sales and operating loss will be disclosed, allowing comparison with the KRW 1.055 billion sales target and the execution of planned facility spending.
Whether first-quarter 2027 sales recover from the third-quarter 2026 level and whether revenue from the semiconductor module contract appears in quarterly results are the points to watch.
When the detailed implementation schedule for reused-battery inspection rules and ESS safety diagnostic standards is set is the key checkpoint for demand expansion.
Mintech is a company whose battery diagnostic equipment based on electrochemical impedance spectroscopy has been described by KB Securities as commercialized in Korea, with 2025 annual sales of KRW 21 billion and an operating loss of KRW 8.8 billion.
An operating loss was recorded in each of the three years from 2023 through 2025, though the loss narrowed in 2025 from the prior year. Quarterly sales fell to KRW 1.61 billion, KRW 1.54 billion and KRW 844 million during 2026, and third-quarter sales were down 91.9% from a year earlier.
Operating losses narrowed in the second and third quarters of 2026, and third-quarter owner net income turned to a KRW 33.88 million profit. Bullish factors are demand from the reused-battery inspection rules and the KRW 10.87 billion semiconductor module inspection contract.
Bearish factors are the sales decline, owner net losses of KRW 6.88 billion over the latest four quarters, and dependence on the timing of battery-related rules.
The next checkpoints are the 2026 annual report due in late March 2027 and first-quarter 2027 results, where sales recovery and the recognition of contract revenue will determine the outcome. This material is provided for information only and does not include a buy or sell opinion.
Report written 2026-11-14 · Data as of 2026-11-13
This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.